BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Yang X, Zhu XL, Bai H, Wang ZZ, Zhang JJ, Hao CY, Duan HB. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. Aging (Albany NY) 2021;13:15459-78. [PMID: 34148033 DOI: 10.18632/aging.203103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma K, Chen S, Chen X, Yang C, Yang J. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas. World Neurosurg 2022:S1878-8750(22)00909-3. [PMID: 35779750 DOI: 10.1016/j.wneu.2022.06.124] [Reference Citation Analysis]
2 Iglesia RP, Prado MB, Alves RN, Escobar MIM, Fernandes CFDL, Fortes ACDS, Souza MCDS, Boccacino JM, Cangiano G, Soares SR, Araújo JPAD, Tiek DM, Goenka A, Song X, Keady JR, Hu B, Cheng SY, Lopes MH. Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression. Front Cell Dev Biol 2022;10:907423. [DOI: 10.3389/fcell.2022.907423] [Reference Citation Analysis]
3 Wang L, Lv P, Lou Y, Zhang Z. Alarm Signal S100-Related Signature Is Correlated with Tumor Microenvironment and Predicts Prognosis in Glioma. Disease Markers 2022;2022:1-22. [DOI: 10.1155/2022/4968555] [Reference Citation Analysis]
4 Zhao Z, Wang Z, Wu Y, Liao D, Zhao B. Comprehensive analysis of TAMs marker genes in glioma for predicting prognosis and immunotherapy response. Molecular Immunology 2022;144:78-95. [DOI: 10.1016/j.molimm.2022.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Q, Xia T, Qi C, Du J, Ye C. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09180-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ye W, Liu Z, Liu F, Luo C. Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas. Front Cell Dev Biol 2021;9:760800. [PMID: 34858984 DOI: 10.3389/fcell.2021.760800] [Reference Citation Analysis]
7 Bharadwaj AG, Kempster E, Waisman DM. The ANXA2/S100A10 Complex—Regulation of the Oncogenic Plasminogen Receptor. Biomolecules 2021;11:1772. [DOI: 10.3390/biom11121772] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Wei J, Gilboa E, Calin GA, Heimberger AB. Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment. Front Oncol 2021;11:682129. [PMID: 34532286 DOI: 10.3389/fonc.2021.682129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]